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Genetic mutations are useful biomarkers for cancer to assess genetic risk, classify cancer subtype, and to 
predict and monitor treatment efficacy. Epigenetic modifications are gaining interest since they can 
complement the mutation information. The combined genetic and epigenetic data have higher diagnostic 
and prognostic value than the two approaches applied separately for several types of cancer. Here, we 
present a method to simultaneously genotype mutation and methylation events on giant magnetoresistive 
(GMR) biosensor arrays. We investigated five mutation sites in BRAF and NRAS genes and the 
methylation status of RARB and KIT promoters. We analysed genetic material from seven human 
melanoma cell lines from the European Searchable Tumour Line Database to compare our method with 
traditional techniques.1,2 
 
To genotype mutation, we used a hybridization assay followed by melting curve measurement.3 The 
GMR biosensor chips (Figure 1a) consisted of 64 single GMR sensors. The surface of each sensor was 
functionalized with ssDNA probes complementary to the wild type (WT) or mutant type (MT) target 
sequences. Biotinylated PCR products were labelled with magnetic nanoparticles. Upon hybridization to 
the surface probes, the nanoparticles were tethered to the sensor surface and their magnetic dipole field 
quantified by the GMR sensors.4 After hybridization, melting curves were measured by ramping up the 
chip temperature (Figure 1b). The difference in melting temperature between the probes ΔTm is indicative 
of the mutation status of the cell line (Figure 2). The threshold values for ΔTm in Figure 3 were used for 
genotyping and the results were found to agree with previous studies.1,2 
 
To investigate methylation status, we employed bisulphite conversion to translate a methylation event in a 
single point mutation. The measured ΔTm values (Figure 4) were found to correlate linearly with 
methylation density measurements by bisulphite pyrosequencing. GMR biosensors allowed for 
simultaneous mutation genotyping and quantitative methylation analysis. 
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Figure 1: (a) GMR biosensor array mounted in the 
temperature-controlled chip holder. (b) Schematic of the 
melting curve assay: ss-DNA PCR products are bound to an 
allele-specific DNA probe tethered to the surface of the GMR 
sensor. The target is labelled with streptavidin coated 
magnetic nanoparticles using biotinylated primers. Upon 
heating, the DNA hybrids denature causing a decrease of the 
magnetic signal. 
 
Figure 2: Melting curves measured for WT (blue) and MT 
(red) probes targeting BRAF c.1799T>A single point mutation. 
Curves measured for (a) wild type EST045 and (b) 
heterozygous mutant EST018 cell lines. Melting temperatures 
corresponds to halved signal. 
 
 
 
Figure 3: Genotyping of BRAF mutations in EST cell lines. 
ΔTm was measured from melting curves. Probes for BRAF 
c.1391 G>A and BRAF c.1799 T>A mutations were used. 
Horizontal lines correspond to genotyping threshold values 
and divide sample in heterozygous WT, homozygous and 
heterozygous MT. Genotyping results were consistent with 
traditional methods. 
 
Figure 4: Melting temperature difference measured with 
methylation DNA probes vs methylation density measured by 
bisulphite pyrosequencing.3 Methylation level was measured 
for two locations in both KIT (a) and RARB (b) promoter 
regions. ΔTm correlates linearly with the methylation density.3
 
 
 
 
